Global Veterinary Paraciticide Market Size By Type (Oral Liquids, Tablets), By Application (Companion Animals, Farm Animals), By Region, And Segment Forecasts, 2023 to 2032

lobal Veterinary Parasiticide Market Report Description

The Global Veterinary Parasiticide Market was valued at USD 9.3 billion in 2023 and is projected to reach USD 15.4 billion by 2031, growing at a CAGR of 6.0% during the forecast period from 2023 to 2031. This growth is driven by increasing awareness of animal health, the rising prevalence of zoonotic diseases, and a surge in demand for effective parasite control solutions in both companion and livestock animals. The growing pet population and rising expenditure on pet care, alongside the intensification of livestock farming, are further fueling market expansion globally.

Drivers

1. Growing Pet Ownership and Spending on Companion Animal Health

The increasing number of pet owners, particularly in urban areas, is driving the demand for parasiticides as part of routine preventive healthcare. Rising disposable incomes and growing awareness of veterinary wellness have significantly boosted market demand.

2. Rise in Zoonotic Disease Incidence

The threat of zoonotic diseases transmitted from animals to humans has made parasitic control a priority. Governments and veterinary organizations globally are promoting parasite prevention programs, propelling market growth.

3. Expansion of Livestock Farming

Commercial livestock operations are expanding to meet global food demand. These operations require regular deworming and ectoparasite control, boosting demand for parasiticides in the cattle, sheep, and poultry sectors.

Restraints

1. Stringent Regulatory Approval Processes

Veterinary pharmaceuticals, especially parasiticides, face stringent approval processes in many regions. This can delay product launches and increase R&D costs.

2. Adverse Effects and Drug Resistance

Concerns about side effects in animals and the growing issue of resistance to antiparasitic drugs are acting as constraints to wider adoption, necessitating the development of more effective formulations.

Opportunity

1. Innovation in Broad-Spectrum and Long-Acting Formulations

The market is witnessing strong investment in R&D to develop long-acting and combination parasiticides that target both internal and external parasites. These products offer enhanced efficacy and compliance.

2. Growth Potential in Emerging Markets

Rising livestock production and growing pet adoption in emerging economies, particularly in Asia-Pacific and Latin America, offer untapped opportunities. Increasing veterinary service penetration is supporting market entry and growth.

Market by System Type Insights

The Ectoparasiticides segment held the largest market share in 2023. These products are used extensively for controlling fleas, ticks, and mites, especially in companion animals. Spot-on treatments, sprays, and collars are in high demand due to ease of application and high efficacy.

The Endoparasiticides segment is expected to grow at the fastest rate, driven by rising concerns over gastrointestinal and systemic parasitic infections in both pets and livestock.

Market by End-use Insights

Companion Animals dominated the market in 2023, fueled by increased pet care expenditure and awareness of preventive healthcare. The routine use of parasiticides in dogs and cats for flea, tick, and heartworm control contributes significantly to revenue.

Livestock is also a major contributor, with cattle, sheep, and poultry requiring regular antiparasitic treatments to ensure productivity, health, and compliance with food safety standards.

Market by Regional Insights

North America led the global veterinary parasiticide market in 2023, supported by strong veterinary healthcare infrastructure, high pet ownership rates, and presence of leading pharmaceutical companies.

Asia-Pacific is expected to exhibit the fastest growth during the forecast period due to increasing livestock population, government initiatives for animal health, and growing pet care awareness in countries like China, India, and Indonesia.

Competitive Scenario

Key players in the global veterinary parasiticide market include Zoetis Inc., Boehringer Ingelheim, Merck Animal Health, Elanco Animal Health, Ceva Santé Animale, Vetoquinol, Virbac, Norbrook Laboratories, Bayer AG, and Dechra Pharmaceuticals. These companies are investing in innovative formulations, strategic collaborations, and regional expansions.

In 2023, Zoetis launched a new long-acting injectable parasiticide for cattle, aiming at improved compliance and reduced labor costs.

Boehringer Ingelheim announced partnerships with tele-veterinary platforms to improve access to parasite control products in remote areas.

Elanco Animal Health expanded its parasiticide portfolio in Latin America through acquisition of regional players in 2024.

Scope of Work – Global Veterinary Parasiticide Market

Key Market Developments

2023: Zoetis introduced a novel parasiticide for dogs combining flea, tick, and worm protection in a single chewable tablet.

2024: Elanco acquired a regional parasiticide manufacturer in Brazil to strengthen its distribution network in Latin America.

2025: Virbac launched a wearable parasiticide collar with extended-release technology for flea and tick protection lasting up to 8 months.

FAQs

1) What is the current market size of the Global Veterinary Parasiticide Market?

The market was valued at USD 9.3 billion in 2023.

2) What is the major growth driver of the Global Veterinary Parasiticide Market?

The major growth driver is the rising awareness of animal health and increasing prevalence of zoonotic diseases.

3) Which is the largest region during the forecast period in the Global Veterinary Parasiticide Market?

North America is the largest regional market, while Asia-Pacific is projected to grow the fastest.

4) Which segment accounted for the largest market share in the Global Veterinary Parasiticide Market?

The Ectoparasiticides segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Veterinary Parasiticide Market?

Key players include Zoetis Inc., Boehringer Ingelheim, Merck Animal Health, Elanco Animal Health, Ceva Santé Animale, and Virbac.

Let me know if you’d like this exported as a document or tailored for a presentation format.